SavedAdd your journal

Journals / The European Research Journal / 2020 / Cilt: 6 - Sayı: 6

Prophylactic and therapeutic parotidectomy for secondary neoplasms of the parotid gland

Samet Özlügedik
Caner Kılıç
Tuncay Tunçcan
Arzubetül Duran
Ayça Ant
Felat Toprak
Pages
561–568
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The most common indication of parotidectomy (prophylactic and therapeutic) andpathology of parotid mass due to SNP and Cutaneous Squamous Cell Carcinoma (SCC) (36.3% and 50%,respectively).Conclusions: Owing to rapidly progressive feature and high morbidity, close observation of parotid in case ofmetastasis is crucial for recurrent SCC of the face and scalp.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:ABSTRACTObjectives: The aim of this study was to review the demographic and clinicopathological findings of thepatients who underwent prophylactic or therapeutic parotidectomy due to the secondary neoplasm of the parotidgland (SNP), the outcomes of the patients with SNP and to provide a perspective to the parotid and neckapproach in head and neck skin cancer cases.Methods: The clinical data of 178 patients who underwent parotidectomydue to neoplasm in the Departmentof Otorhinolaryngology, Head and Neck Surgery of a tertiary referral center from 2012 to 2017 were reviewed.Results: Among 178 patients, twenty-two (12.4%) patients were found to underwentprophylactic or therapeuticparotidectomy due to SNP.
📊
Key Findings & Data:The median age of six patients was 67 years (ranging from 2 to 83 years).
💡
Conclusion & Impact:The most common indication of parotidectomy (prophylactic and therapeutic) andpathology of parotid mass due to SNP and Cutaneous Squamous Cell Carcinoma (SCC) (36.3% and 50%,respectively).Conclusions: Owing to rapidly progressive feature and high morbidity, close observation of parotid in case ofmetastasis is crucial for recurrent SCC of the face and scalp.
🔬Design:Review & Systematic Survey
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

ABSTRACTObjectives: The aim of this study was to review the demographic and clinicopathological findings of thepatients who underwent prophylactic or therapeutic parotidectomy due to the secondary neoplasm of the parotidgland (SNP), the outcomes of the patients with SNP and to provide a perspective to the parotid and neckapproach in head and neck skin cancer cases.Methods: The clinical data of 178 patients who underwent parotidectomydue to neoplasm in the Departmentof Otorhinolaryngology, Head and Neck Surgery of a tertiary referral center from 2012 to 2017 were reviewed.Results: Among 178 patients, twenty-two (12.4%) patients were found to underwentprophylactic or therapeuticparotidectomy due to SNP. Six of these patients had pathologically positive parotid metastases (therapeuticparotidectomy). The median age of six patients was 67 years (ranging from 2 to 83 years). Five patients weremale and one was female. The most common indication of parotidectomy (prophylactic and therapeutic) andpathology of parotid mass due to SNP and Cutaneous Squamous Cell Carcinoma (SCC) (36.3% and 50%,respectively).Conclusions: Owing to rapidly progressive feature and high morbidity, close observation of parotid in case ofmetastasis is crucial for recurrent SCC of the face and scalp.

🔖

Cite This Article

Özlügedik, S., Kılıç, C., Tunçcan, T., Duran, A., Ant, A., Toprak, F. (2022). Prophylactic and therapeutic parotidectomy for secondary neoplasms of the parotid gland. The European Research Journal, Cilt: 6 - Sayı: 6, 561–568. https://ajindex.com/articles/597456

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Nuyens M, Schupbach J, Stauffer E, Zbaren P. Metastatic disease to the parotid gland. Otolaryngol Head Neck Surg 2006;135:844-8
  2. D’Souza J, Clark J. Management of the neck in metastatic cutaneous squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg 2011;19:99-105
  3. Lukšić I, Virag M, Manojlović S, Macan D. Salivary gland tumours: 25 years of experience from a single institution in Croatia. J Craniomaxillofac Surg 2012;40:e75-81
  4. Barnes L, Eveson JW, Reichart P, Sidransky D. (Eds.): World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. IARC Press: Lyon, 2005
  5. Franzen AM, Günzel T, Lieder A. Parotid gland metastasesof distant primary tumours: a diagnostic challenge. Auris Nasus Larynx 2015;29:187-91
  6. Pomar Blanco P, Martín Villares C, San Román Carbajo J, Tapia Risueño M, Fernández Pello M. [Metastasis to the parotid gland]. Acta Otorrinolaryngol Esp 2006;57:47-50. [Article in Spanish] 7. Rouviere H. Anatomy of the Human Lymphatic System (Tobias JM, translator.) Ann Arbor, Edward Brothers, 1938
  7. Schroeder WA, Stahr WD. Malignant neoplastic disease of the parotid lymph nodes. Laryngoscope 1998;108:1514-9
  8. Zbaren P, Schar C, Hotz MA, Loosli H. Value of fine-needle aspiration cytology of parotid gland masses. Laryngoscope 2001;111:1989-92
  9. Lydiatt WM, Patel SG, O'Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, et al. Head and neck cancers - major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin 2017;67:122-37
  10. Stratigos A, Garbe C, Lebbe C, Malvehy J, Del Marmol V, Pehamberger H, et al. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur J Cancer 2015;51:1989-2007
  11. Jambusaria-Pahlajani A, Miller CJ, Quon H, Smith N, Klein RQ, Schmults CD. Surgical monotherapy versus surgery plus adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma: a systematic review of outcomes. Dermatol Surg 2009;35:574-85
  12. Wong WK, Morton RP. Elective management of cervical and parotid lymph nodes in stage N0 cutaneous squamous cell carcinoma of the head and neck: a decision analysis. Eur Arch Otorhinolaryngol 2014;271:3011-9
  13. Skulsky SL, O'Sullivan B, McArdle O, Leader M, Roche M, Conlon PJ, et al. Review of high-risk features of cutaneous squamous cell carcinoma and discrepancies between the American Joint Committee on